(Total Views: 604)
Posted On: 01/03/2020 2:58:54 AM
Post# of 150024
Re: ClosetInvestor #14194
From a revenue standpoint, NASH, monotherapy or the basket cancer trial would be better.
(0)
(0)Scroll down for more posts ▼
